AtriCure Gains 10%+ After Hours on Q3 Sales Beat and Narrower-Than-Expected Loss
AtriCure Gains 10%+ After Hours on Q3 Sales Beat and Narrower-Than-Expected Loss
AtriCure在第三季销售超预期并实现亏损幅度较小后盘后上涨10%以上
$AtriCure (ATRC.US)$ rose more than 10% after hours Tuesday after the biotech reported a narrower Q3 loss than expected and beat analyst expectations for revenues.
$AtriCure (ATRC.US)$ 在周二盘后，该生物科技公司公布的第三季度亏损比预期的较小，并且超出分析师对收入的预期后，其股价上涨超过10%。
ATRC gained 13.8% to $33.50 shortly after 5 p.m. ET after reporting a $0.17 loss per share, which beat the $0.19 that analysts' consensus had called for.
在下午5点过后不久，atricle的股价上涨了13.8%，达到33.50美元，此时该公司每股亏损0.17美元，超过了分析师预期的0.19美元。
The company also said quarterly sales came in at $115.9 million, exceeding analysts' consensus forecast of $112.3 million. Sales also rose 17.9% year over year.
该公司还表示季度销售额达到11590万美元，超出分析师11230万美元的共识预测。销售额同比增长了17.9%。
热门讨论
科技巨头财报季如火如荼，英伟达压轴会表现如何？
星期四， $亚马逊 (AMZN.US)$ 股价在公司报告第四季度调整后每股收益为1.86美元，预估为每股1.50美元，营业收入为1877.9亿，预估为1873.2亿后下跌。该公司预测第一季度的营业收入数字低于华尔街的预期，预测本季度最多为1550亿，而分析师希望为1580亿。 星
Moo Earnings
02/02 12:39
亚马逊盈利预告：猜测开盘价，获取奖励！